441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
Titel:
441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
Auteur:
Ma, B.B.Y. Rudin, C.M. Cervantes, A. Dowlati, A. Costa, D. Schmid, P. Heist, R. Villaflor, V.M. Sarkar, I. Huseni, M.A. Foster, P. O’Hear, C. Gettinger, S. Besse, B.